ISSN: 1812-9269

Journal Home

Journal Guideline

Experimental Oncology Q4 Unclaimed

Morion LLC Ukraine

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Experimental Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 48. It has an SJR impact factor of 0,25 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,25.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q4) Oncology (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,25

SJR Impact factor

48

H Index

42

Total Docs (Last Year)

196

Total Docs (3 years)

1233

Total Refs

149

Total Cites (3 years)

189

Citable Docs (3 years)

0.62

Cites/Doc (2 years)

29.36

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Biological Regulators and Homeostatic Agents Q4
Chinese Journal of Oncology Q4
Middle East Journal of Cancer Q4
Acta Haematologica Polonica Q4
European Journal of Oncology Pharmacy Q4

Compare this journals

Aims and Scope

Best articles by citations

PROGNOSTIC VALUE OF THE BONE TURNOVER MARKERS IN MULTIPLE MYELOMA

PARANEOPLASTIC SYNDROME IN LUNG CANCER

A CASE REPORT OF LATE LOCAL RELAPSE OF ADRENOCORTICAL CARCINOMA 18 YEARS AFTER ADRENALECTOMY

Insights into the mechanism of natural terpenoids as NF-kB inhibitors: an overview on their anticancer potential

A RARE CLINICAL CASE OF THE ISOLATED PRIMARY FRONTAL BONE OSTEOMA

CHRONIC MYELOID LEUKEMIA IN PATIENT WITH THE KLINEFELTER SYNDROME

TISSUE-ENGINEERED BONE FOR TREATMENT OF COMBAT RELATED LIMB INJURIES

ANTI-CANCER EFFICIENCY OF NATURAL KILLER CELLS DIFFERENTIATED FROM HUMAN ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS AND TRANSFECTED WITH miRNA150

metastasis of two malignant tumors of different genesis in axillary lymph node (a case report)

ESTABLISHMENT AND CHARACTERIZATION OF NEW BREAST AND OVARIAN CANCER CELL LINES AS A MODEL FOR STUDYING CELLULAR PLASTICITY IN VITRO

CORRELATION OF IODINE SYMPORTER EXPRESSION IN HIGHLY AND LOW MALIGNANT CELL LINES OF HUMAN BREAST CANCER DIFFERED IN THEIR SENSITIVITY TO DOXORUBICIN

EFFECT OF CYTOSTATIC AGENTS ON EXPRESSION LEVELS OF HUMAN BETA-DEFENSINS-1-4 IN A431 AND MCF-7 CELL LINES

SHOW MORE ARTICLES

L-ARGININE IS AN EFFECTIVE MEDICATION FOR PREVENTION OF ENDOTHELIAL DYSFUNCTION, A PREDICTOR OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH ACUTE LEUKEMIA

SERGIY PETROVYCH OSINSKY

SENSITIVITY TO 4-HYDROXYESTRADIOL AND DNA REPAIR EFFICIENCY IN PERIPHERAL BLOOD LYMPHOCYTES OF ENDOMETRIAL CANCER PATIENTS

CLINICOPATHOLOGICAL FEATURES OF NONSPECIFIC INVASIVE BREAST CANCER ACCORDING TO ITS MOLECULAR SUBTYPES

Photocytotoxic effect of c60 fullerene against l1210 leukemic cells is accomPanied by enhanced nitric oxide Production and p38 maPk activation

SMOKING-RELATED DNA ADDUCTS AS POTENTIAL DIAGNOSTIC MARKERS OF LUNG CANCER: NEW PERSPECTIVES

THE EFFICACY OF TISSUE FACTOR -603A/G AND +5466A>G POLIMORPHISMS AT THE DEVELOPMENT OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS

HEPCIDIN AS A POSSIBLE MARKER IN DETERMINATION OF MALIGNANCY DEGREE AND SENSITIVITY OF BREAST CANCER CELLS TO CYTOSTATIC DRUGS

USE OF ELASTOGRAPHY FOR CERVICAL CANCER DIAGNOSTICS

DANIIL F. GLUZMAN (ON THE 80TH BIRTH ANNIVERSARY)

Aberrant expression of placental-like alkaline phosphatase in chronic myeloid leukemia cells in vitro and its modulation by vitamin E

RADIOPROTECTIVE PROPERTIES OF SODIUM HUMATE IN RADIATION-INDUCED MUTAGENESIS IN CULTURED LYMPHOCYTES OF THYROID CANCER PATIENTS